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May 20101324 Abstractspredicting failure are lacking. This study investigated patient characteristics
with predictive value for restenosis during the first year after RSFAE.
Design: A prospective cohort study.
Materials and methods: A total of 90 patients post-RSFAE were
studied for the occurrence of restenosis “(peak systolic velocity ratio 2.5)”
in the first 12 months postoperatively. At baseline, clinical parameters were
recorded. Vessel size was measured on the basis of plaque perimeter in the
culprit lesion and lumen diameter on perioperative digital subtraction an-
giography.
Results: In 57 patients (63%), a restenotic lesion was diagnosed within
12 months following surgery. Patients with longer time interval between
start of ischaemic walking complaints and RSFAE revealed a significantly
higher incidence of restenosis (hazard ratio (HR)  1.3 (1.05–1.52) per 4
years). Small plaque perimeter and small superficial femoral artery (SFA)
diameter on angiography were significantly associated with restenosis
(HR  0.54 (0.34–0.88) per 10 mm and HR  0.46 (0.27–0.78) per
1.5 mm, respectively). In multivariate analysis, age, duration of ischaemic
walking complaints and lumen diameter were independently associated with
increased risk of restenosis after RSFAE.
Conclusions: This study provides evidence that age, vessel size and
duration of ischaemic walking complaints before RSFAE are predictive
values for restenosis after RSFAE.
Basilic Vein Transposition: What is the Optimal Technique?
Kakkos S.K., Haddad G.K., Weaver M.R., Haddad R.K., Scully M.M. Eur J
Vasc Endovasc Surg 2010;39:in press.
Objectives: To compare the outcome of the one-stage basilic vein
transposition (BVT) fistula with a modified, two-stage technique.
Design: Retrospective case-controlled study, performed in an aca-
demic centre.
Material:A total of 173 candidates for BVT fistula (87males, mean age
61 years).
Methods: In one-stage BVT, the basilic vein is mobilised through a
single incision, placed inside an anterolateral arm tunnel and anastomosed
with the brachial artery. In two-stage procedures, the fistula–arterial anasto-
mosis is created first, followed by the second stage, after fistula maturation
several weeks later, when the basilic vein is mobilised through two skip
incisions, transected near the anastomosis, placed inside an anterolateral arm
tunnel and reanastomosed. Morbidity and fistula maturation rate were the
main outcome measures.
Results: In one-stage BVT (n  76), the incidence of venous hyper-
tension, wound haematomas and all complications (17%, 13% and 43%,
respectively) was significantly higher than in two-stage procedures (n  98)
(4%, p  0.004, 3%, p  0.012 and 11%, p  0.001, respectively). Time (68
days) to fistula use was significantly decreased in one-stage BVT than in
two-stage procedures (132 days, p  0.001) but failure to mature rate was
equivalent (15% vs. 18%, p  0.49).
Conclusions: Our results indicate that the two-stage BVT fistula
through two skip-arm incisions is superior to the established one-stage
procedure in terms of less morbidity but at the cost of a second operation
and longer time to access use. Further research comparing these twoReaders can access EJVES articles at http://intl.eRandomised Clinical Trial Comparing Endovenous Laser Ablation
with Stripping of the Great Saphenous Vein: Clinical Outcome and
Recurrence After 2 Years
Rasmussen L.H., Bjoern L., Lawaetz M., Lawaetz B., Blemings A., Eklöf B.
Eur J Vasc Endovasc Surg 2010;39:in press.
Objective: This study aims to compare the outcome 2 years after
treatment of varicose veins by endovenous laser ablation (EVLA) or surgery
by assessing recurrence, venous clinical severity score (VCSS) and quality of
life.
Methods: A total of 121 patients (137 legs) were randomised to either
EVLA or saphenofemoral ligation and stripping of the great saphenous vein
(GSV). Follow-up included clinical and duplex ultrasound examinations,
VCSS and quality of life questionnaires.
Results: A total of 18 (26%) and 25 patients (37%) in the EVLA and
surgery group, respectively, developed recurrent varicose veins (not signifi-
cant (NS) between groups). The source of reflux was not significantly
different between the groups. Technical failure occurred in three EVLA and
two surgery patients, reflux in the anterior accessory GSV, the groin, thigh
and calf perforators was found in six, two, four, and three EVLA patients,
and in three, three, nine and six surgery patients. VCSS, Aberdeen Varicose
Vein Severity Score and several domains of the Medical Outcomes Study
Short Form 36 (SF36) quality of life score improved significantly in both
groups.
Conclusions:No significant differences in clinical or ultrasound recur-
rences were found between EVLA and surgery groups. Our study also shows
that similar improvements in clinical severity scores and quality of life were
gained in both treatments.
Primary Lymphoedema and Lymphatic Malformation: Are they the
Two Sides of the Same Coin?
Lee B.B., Villavicencio J.L. Eur J Vasc Endovasc Surg 2010;39:in press.
Objectives: To clear the confusion regarding the relationship between
the ‘primary lymphoedema’ and (truncular) lymphatic malformation (LM);
the latter is one of congenital vascular malformations.
Materials & Methods: A literature review was carried out on the
primary lymphoedema either existing as an independent LM lesion or as a
component of the Klippel–Trenaunay syndrome.
Results: The review was able to provide a contemporary guide/
conclusion on the definition and classification, clinical evaluation and clinical
management regarding conservative (physical) therapy, reconstructive sur-
gical therapy and ablative/excisional surgical therapy, for the primary lym-
phoedema as an LM.
Conclusions: Primary lymphoedema can be considered as ‘congenital’
since its majority represents a clinical manifestation of the truncular type of
LM arising during the later stages of lymphangiogenesis. Such embryolog-
ical staging information of the LM is critical for proper management of the
primary lymphoedema when it exists with other congenital vascular malfor-
mations (Klippel–Trenaunay syndrome).
2. Basic non-invasive to minimally invasive tests will provide an ade-
quate diagnosis and lead to the correct multidisciplinary, specifically targeted
and sequenced treatment strategy.
3. The mainstay of current management of the primary lymphoedema/
techniques is necessary. Until this issue is resolved, an individualised ap-
proach is suggested.
truncular LM is complex decongestive therapy; and the reconstructive as
well as ablative surgical therapy remain adjunctive therapies at best.lsevierhealth.com/journals/ejvs/default.cfm
